120 related articles for article (PubMed ID: 31670607)
1. Absent Diurnal Variation in Serum Testosterone in Young Men with Testosterone Deficiency.
Shlykova N; Davidson E; Krakowsky Y; Bolanos J; Traish A; Morgentaler A
J Urol; 2020 Apr; 203(4):817-823. PubMed ID: 31670607
[TBL] [Abstract][Full Text] [Related]
2. Analysis of diurnal variation in serum testosterone levels in men with symptoms of testosterone deficiency.
Novaes LF; Flores JM; Benfante N; Schofield E; Katz DJ; Nelson CJ; Mulhall JP
J Sex Med; 2024 Apr; 21(5):408-413. PubMed ID: 38481019
[TBL] [Abstract][Full Text] [Related]
3. Modeling of circadian testosterone in healthy men and hypogonadal men.
Gupta SK; Lindemulder EA; Sathyan G
J Clin Pharmacol; 2000 Jul; 40(7):731-8. PubMed ID: 10883414
[TBL] [Abstract][Full Text] [Related]
4. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.
Diver MJ; Imtiaz KE; Ahmad AM; Vora JP; Fraser WD
Clin Endocrinol (Oxf); 2003 Jun; 58(6):710-7. PubMed ID: 12780747
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age.
Pastuszak AW; Gittelman M; Tursi JP; Jaffe JS; Schofield D; Miner MM
Andrology; 2022 Feb; 10(2):209-222. PubMed ID: 34510812
[TBL] [Abstract][Full Text] [Related]
6. The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations.
Collier CP; Morales A; Clark A; Lam M; Wynne-Edwards K; Black A
J Urol; 2010 Jun; 183(6):2294-9. PubMed ID: 20400148
[TBL] [Abstract][Full Text] [Related]
7. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
8. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men.
Plymate SR; Tenover JS; Bremner WJ
J Androl; 1989; 10(5):366-71. PubMed ID: 2592266
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus.
Javanbakht M; Singh AB; Mazer NA; Beall G; Sinha-Hikim I; Shen R; Bhasin S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2395-401. PubMed ID: 10902784
[TBL] [Abstract][Full Text] [Related]
10. Middle-aged men secrete less testosterone at night than young healthy men.
Luboshitzky R; Shen-Orr Z; Herer P
J Clin Endocrinol Metab; 2003 Jul; 88(7):3160-6. PubMed ID: 12843160
[TBL] [Abstract][Full Text] [Related]
11. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
Kim ED; McCullough A; Kaminetsky J
BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621
[TBL] [Abstract][Full Text] [Related]
12. Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model.
Cooke RR; McIntosh JE; McIntosh RP
Clin Endocrinol (Oxf); 1993 Aug; 39(2):163-71. PubMed ID: 8370129
[TBL] [Abstract][Full Text] [Related]
13. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men].
Rabijewski M; Papierska L; Kozakowski J; Zgliczyński W
Endokrynol Pol; 2007; 58(6):496-504. PubMed ID: 18205106
[TBL] [Abstract][Full Text] [Related]
15. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.
Bremner WJ; Vitiello MV; Prinz PN
J Clin Endocrinol Metab; 1983 Jun; 56(6):1278-81. PubMed ID: 6841562
[TBL] [Abstract][Full Text] [Related]
16. Return of gonadal function in men with prolactin-secreting pituitary tumors.
Murray FT; Cameron DF; Ketchum C
J Clin Endocrinol Metab; 1984 Jul; 59(1):79-85. PubMed ID: 6427273
[TBL] [Abstract][Full Text] [Related]
17. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men.
Mermall H; Sothern RB; Kanabrocki EL; Quadri SF; Bremner FW; Nemchausky BA; Scheving LE
Urology; 1995 Jul; 46(1):45-53. PubMed ID: 7541585
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
[TBL] [Abstract][Full Text] [Related]
20. Testosterone 2% gel can normalize testosterone concentrations in men with low testosterone regardless of body mass index.
Dobs A; Norwood P; Potts S; Gould E; Chitra S
J Sex Med; 2014 Mar; 11(3):857-64. PubMed ID: 24283410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
